Safety and Tolerability of PF-06818883 in Healthy Subjects
NCT03020784 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-12-11
Summary
Safety, Tolerability and Pharmacokinetics of PF-06818883
Conditions
- Healthy
Interventions
- DRUG
-
Placebo
- DRUG
-
PF-06818883
Treatment
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-11
- Primary Completion
- 2017-06-13
- Completion
- 2017-06-13
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
NCT03092232 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers
NCT00971802 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects
NCT01794364 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234
NCT02711462 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers
NCT00992342 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study of PF-05230907 in Healthy Japanese Subjects
NCT02537002 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859
NCT02766621 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants
NCT05037409 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects
NCT02539550 ·Status: COMPLETED ·Phase: PHASE1
-
First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects
NCT03309241 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults
NCT06137729 ·Status: TERMINATED ·Phase: PHASE1
-
Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects
NCT02485769 ·Status: COMPLETED ·Phase: PHASE1
-
OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS
NCT03871439 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants
NCT05654181 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers
NCT01247883 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects
NCT01626976 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults
NCT06821750 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults
NCT05907395 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals
NCT01089738 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants
NCT04388878 ·Status: COMPLETED ·Phase: PHASE1
-
A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants
NCT05434091 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions
NCT02224651 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Dose Study in Healthy Volunteers to Assess Safety, Pharmacokinetics and Pharmacodynamics of PF 03882845
NCT00856258 ·Status: TERMINATED ·Phase: PHASE1
-
To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers
NCT01045863 ·Status: TERMINATED ·Phase: PHASE1
-
Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects
NCT03599063 ·Status: COMPLETED ·Phase: PHASE1